Would you like to be notified of the latest news and updates on the stock market?
Jefferies initiates buy on Krystal Biotech with a $245 price target, citing Vyjuvek's strong growth potential and proprietary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback